The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop. Read More
Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years. One stock that investors have become less enamored with, however, is Johnson & Johnson. Read More
Activist investor Daniel Loeb continues to put the heat on Yahoo, Cisco earnings beat but stock falls as they warn on outlook, Facebook says its mobile growth is growing faster than its advertising platform can keep up. Read More
In 2011, Mylan’s longtime chief executive Robert Coury, who gave up the post at the end of the year to become executive chairman (he’s also chairman of the board) earned cash compensation of $7.4 million. Read More